Investor Says Abbott Laboratories Hid Formula Plant Woes
An Abbott Laboratories stockholder has launched a derivative suit accusing the company's leadership of misleading investors by hiding what they knew about contamination at one of Abbott's infant formula plants....To view the full article, register now.
Already a subscriber? Click here to view full article